News coverage about Organovo Holdings (NASDAQ:ONVO) has been trending somewhat positive recently, according to Accern. Accern identifies positive and negative media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Organovo Holdings earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.4236243399688 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:
- Organovo Holdings, Inc. (ONVO)- Most Active Performers for the Day – NASDAQ Times (nasdaqtimes.com)
- Organovo Holdings, Inc. (ONVO)- Stocks Ringing Performance Alarms – NASDAQ Times (nasdaqtimes.com)
- Organovo Holdings, Inc. (ONVO) Just Flashed an Extremely Rare ‘Hold’ Signal – StockNewsGazette (stocknewsgazette.com)
- Now Is The Time To Reconsider Aspen Technology, Inc. (AZPN), Organovo Holdings, Inc. (ONVO) – AllStockNews (allstocknews.com)
- Stock Strong Buy Signal: Organovo Holdings, Inc. (ONVO) ,BioDelivery Sciences International, Inc. (BDSI) – Street Observer (press release) (streetobserver.com)
ONVO has been the topic of a number of analyst reports. Jefferies Group LLC reiterated a “buy” rating and set a $4.00 price objective (down previously from $4.50) on shares of Organovo Holdings in a research note on Thursday, June 8th. Evercore ISI reissued an “outperform” rating and set a $3.75 price target (down previously from $4.00) on shares of Organovo Holdings in a research report on Friday, June 9th. Finally, BidaskClub downgraded shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 25th. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $6.20.
Organovo Holdings (NASDAQ:ONVO) traded down 7.96% during trading on Friday, reaching $1.85. 2,281,344 shares of the company’s stock were exchanged. The stock’s 50-day moving average price is $2.35 and its 200-day moving average price is $2.80. Organovo Holdings has a 52-week low of $1.82 and a 52-week high of $4.28.
Organovo Holdings (NASDAQ:ONVO) last issued its earnings results on Wednesday, August 9th. The company reported ($0.10) EPS for the quarter, meeting analysts’ consensus estimates of ($0.10). The business had revenue of $0.99 million during the quarter, compared to analyst estimates of $0.92 million. Organovo Holdings had a negative return on equity of 65.49% and a negative net margin of 918.97%. The firm’s revenue was up 11.1% compared to the same quarter last year. On average, analysts forecast that Organovo Holdings will post ($0.39) EPS for the current fiscal year.
Organovo Holdings Company Profile
Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with our FREE daily email newsletter.